Cargando…
Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs
Juvenile myelomonocytic leukemia (JMML) is a rare but severe primary hemopoietic system tumor of childhood, most frequent in children 4 years and younger. There are currently no specific anticancer therapies targeting JMML, and the underlying gene expression changes have not been revealed. To define...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
D.A. Spandidos
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6196601/ https://www.ncbi.nlm.nih.gov/pubmed/30272300 http://dx.doi.org/10.3892/or.2018.6709 |